MicroRNA-29b inhibits human vascular smooth muscle cell proliferation via targeting the TGF-β/Smad3 signaling pathway

Li,Lirong; Ren,Shaohua; Hao,Xudong; Zhen,Zigang; Ji,Lei; Ji,Hongming

doi:10.3892/etm.2021.9923

MicroRNA-29b inhibits human vascular smooth muscle cell proliferation via targeting the TGF-β/Smad3 signaling pathway

Authors:
- Lirong Li
- Shaohua Ren
- Xudong Hao
- Zigang Zhen
- Lei Ji
- Hongming Ji
View Affiliations

Affiliations: Department of Neurosurgery of Shanxi Provincial People's Hospital, Taiyuan, Shanxi 030012, P.R. China
Published online on: March 17, 2021 https://doi.org/10.3892/etm.2021.9923
Article Number: 492
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Intracranial aneurysms (IAs) are bulges of blood vessels in the cerebral area. The development and progression of IAs are associated with the proliferation of vascular smooth muscle cells (VSMCs) during phenotypic modulation under environmental cues. MicroRNA-29b (miR-29b) has been studied extensively and demonstrated to reduce cell proliferation in various diseases by binding to the 3'-untranslated region (3'-UTR) of a variety of target messenger RNAs (mRNAs), thereby inhibiting their translation. The present study aimed to investigate the role of miR-29b on the proliferation of VSMCs and human umbilical artery smooth muscle cells. The results indicated that the overexpression of miR-29b reduced cell migration and proliferation. Western blotting results indicated that this effect may be attributed to the attenuation of a signaling pathway involving transforming growth factor β (TGF-β) and Smad3 proteins. Luciferase assay confirmed the binding of miR-29b to TGF-β1 and the knockdown of TGF-β1 reduced miR-29b inhibitor-induced cell migration. The present study indicates that miR-29b downregulates the expression of TGF-β1 by targeting the 3'-UTR of its mRNA and modulates cell migration and proliferation via the TGF-β1/Smad3 signaling pathway.

View Figures

View References

1	Frösen J, Tulamo R, Paetau A, Laaksamo E, Korja M, Laakso A, Niemelä M and Hernesniemi J: Saccular intracranial aneurysm: Pathology and mechanisms. Acta Neuropathol. 123:773–786. 2012.PubMed/NCBI View Article : Google Scholar
2	Bor AS, Rinkel GJ, Adami J, Koffijberg H, Ekbom A, Buskens E, Blomqvist P and Granath F: Risk of subarachnoid haemorrhage according to number of affected relatives: A population based case-control study. Brain. 131:2662–2665. 2008.PubMed/NCBI View Article : Google Scholar
3	Louw DF, Asfora WT and Sutherland GR: A brief history of aneurysm clips. Neurosurg Focus. 11(E4)2001.PubMed/NCBI View Article : Google Scholar
4	Ailawadi G, Moehle CW, Pei H, Walton SP, Yang Z, Kron IL, Lau CL and Owens GK: Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg. 138:1392–1399. 2009.PubMed/NCBI View Article : Google Scholar
5	Nakajima N, Nagahiro S, Sano T, Satomi J and Satoh K: Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls. Acta Neuropathol. 100:475–480. 2000.PubMed/NCBI View Article : Google Scholar
6	Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Owens GK, Koch WJ, Greig NH and Dumont AS: TNF-α induces phenotypic modulation in cerebral vascular smooth muscle cells: Implications for cerebral aneurysm pathology. J Cereb Blood Flow Metab. 33:1564–1573. 2013.PubMed/NCBI View Article : Google Scholar
7	Kawai-Kowase K and Owens GK: Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol. 292:C59–C69. 2007.PubMed/NCBI View Article : Google Scholar
8	Owens GK, Kumar MS and Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 84:767–801. 2004.PubMed/NCBI View Article : Google Scholar
9	Lacolley P, Regnault V, Segers P and Laurent S: Vascular smooth muscle cells and arterial stiffening: Relevance in development, aging, and disease. Physiol Rev. 97:1555–1617. 2017.PubMed/NCBI View Article : Google Scholar
10	Mao N, Gu T, Shi E, Zhang G, Yu L and Wang C: Phenotypic switching of vascular smooth muscle cells in animal model of rat thoracic aortic aneurysm. Interact Cardiovasc Thorac Surg. 21:62–70. 2015.PubMed/NCBI View Article : Google Scholar
11	van Rooij E, Marshall WS and Olson EN: Toward microRNA-based therapeutics for heart disease: The sense in antisense. Circ Res. 103:919–928. 2008.PubMed/NCBI View Article : Google Scholar
12	Small EM and Olson EN: Pervasive roles of microRNAs in cardiovascular biology. Nature. 469:336–342. 2011.PubMed/NCBI View Article : Google Scholar
13	van Rooij E and Olson EN: MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles. Nat Rev Drug Discov. 11:860–872. 2012.PubMed/NCBI View Article : Google Scholar
14	Liu D, Han L, Wu X, Yang X, Zhang Q and Jiang F: Genome-wide microRNA changes in human intracranial aneurysms. BMC Neurol. 14(188)2014.PubMed/NCBI View Article : Google Scholar
15	Yan B, Guo Q, Fu FJ, Wang Z, Yin Z, Wei YB and Yang JR: The role of miR-29b in cancer: Regulation, function, and signaling. Onco Targets Ther. 8:539–548. 2015.PubMed/NCBI View Article : Google Scholar
16	Zhang Y, Huang XR, Wei LH, Chung AC, Yu CM and Lan HY: miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling. Mol Ther. 22:974–985. 2014.PubMed/NCBI View Article : Google Scholar
17	McMullen JR and Bernardo BC: Inhibition of miR-29 protects against cardiac hypertrophy and fibrosis: New insight for the role of miR-29 in the heart. Non-coding RNA Investig. 2(14)2018.
18	Wang G, Matsuura I, He D and Liu F: Transforming growth factor-{beta}-inducible phosphorylation of Smad3. J Biol Chem. 284:9663–9673. 2009.PubMed/NCBI View Article : Google Scholar
19	Sun L, Zhao M, Zhang J, Lv M, Li Y, Yang X, Liu A and Wu Z: MirR-29B downregulation induces phenotypic modulation of vascular smooth muscle cells: Implication for intracranial aneurysm formation and progression to rupture. Cell Physiol Biochem. 41:510–518. 2017.PubMed/NCBI View Article : Google Scholar
20	Fang J, Xu H, Yang C, Morsalin S, Kayarthodi S, Rungsrisuriyachai K, Gunnal U, Mckenzie B, Rao VN and Reddy ES: Ets related gene and Smad3 proteins collaborate to activate transforming growth factor-beta mediated signaling pathway in ETS related gene-positive prostate cancer cells. J Pharm Sci Pharmacol. 1:175–181. 2014.PubMed/NCBI View Article : Google Scholar
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
22	Kole AJ, Swahari V, Hammond SM and Deshmukh M: miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev. 25:125–130. 2011.PubMed/NCBI View Article : Google Scholar
23	Eyholzer M, Schmid S, Wilkens L, Mueller BU and Pabst T: The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Br J Cancer. 103:275–284. 2010.PubMed/NCBI View Article : Google Scholar
24	Tsai S, Hollenbeck ST, Ryer EJ, Edlin R, Yamanouchi D, Kundi R, Wang C, Liu B and Kent KC: TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am J Physiol Heart Circ Physiol. 297:H540–H549. 2009.PubMed/NCBI View Article : Google Scholar
25	Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB, et al: Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol. 160:1057–1068. 2002.PubMed/NCBI View Article : Google Scholar
26	Shi Y and Massagué J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 113:685–700. 2003.PubMed/NCBI View Article : Google Scholar
27	Ma J, Wang Q, Fei T, Han JD and Chen YG: MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration. Blood. 109:987–994. 2007.PubMed/NCBI View Article : Google Scholar
28	Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ and Murphy WJ: Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood. 96:34–40. 2000.PubMed/NCBI
29	Ma F, Li Y, Jia L, Han Y, Cheng J, Li H, Qi Y and Du J: Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS One. 7(e35144)2012.PubMed/NCBI View Article : Google Scholar
30	van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN: Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA. 105:13027–13032. 2008.PubMed/NCBI View Article : Google Scholar
31	Davis-Dusenbery BN, Wu C and Hata A: Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol. 31:2370–2377. 2011.PubMed/NCBI View Article : Google Scholar
32	ten Dijke P and Arthur HM: Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol. 8:857–869. 2007.PubMed/NCBI View Article : Google Scholar
33	Petsophonsakul P, Furmanik M, Forsythe R, Dweck M, Schurink GW, Natour E, Reutelingsperger C, Jacobs M, Mees B and Schurgers L: Role of vascular smooth muscle cell phenotypic switching and calcification in aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 39:1351–1368. 2019.PubMed/NCBI View Article : Google Scholar